VVOS - Vivos Therapeutics, Inc.
2.52
-0.030 -1.190%
Share volume: 49,730
Last Updated: 04-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$2.55
-0.03
-0.01%
Fundamental analysis
14%
Profitability
25%
Dept financing
24%
Liquidity
17%
Performance
0%
Performance
5 Days
-1.95%
1 Month
-21.98%
3 Months
-42.33%
6 Months
4.56%
1 Year
-16.83%
2 Year
713.43%
Key data
Stock price
$2.52
DAY RANGE
$2.37 - $2.58
52 WEEK RANGE
$1.91 - $6.28
52 WEEK CHANGE
-$8.53
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
Company detail
CEO: R. Kirk Huntsman
Region: US
Website: vivos.com
Employees: 160
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: vivos.com
Employees: 160
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Vivos Therapeutics, Inc. develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada.
Recent news
